Search

everythinglearnresearchcommunity

for

Search:↓

Female authorship in dermatology publications increased during the COVID-19 pandemic, but women are still underrepresented in senior roles.

Alopecia Areata has no cure, treatments are limited, and the condition often recurs, but new therapies like JAK inhibitors show promise.

The document is a detailed medical reference on skin and genetic disorders.

Botulinum toxin type A significantly reduces scalp psoriasis severity compared to placebo.

The document concludes that alopecia has significant social and psychological effects, leading to a market for hair loss treatments.

Skin issues from chronic graft-versus-host disease greatly affect daily life, needing teamwork between blood and skin doctors.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

Dormant melanoma cells in mice interact minimally with memory T cells due to a suppressive tumor environment.

Thyroid disease can cause hair loss and treating thyroid problems might help with hair disorders.

Topical immunotherapy with DPCP is most effective for certain alopecia areata types, with success linked to age and disease duration, and influenced by a gene polymorphism.

Transgender patients on hormone therapy experience more acne and hair loss, but less skin inflammation.

Fungi-produced compounds can change plant root growth.

Foxp3 is crucial for regulatory T cell function, and targeting these cells may help treat immune disorders.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.

CRAC channels are crucial for the development and function of specialized immune cells, preventing severe inflammation and autoimmune diseases.

New treatments for hair loss are showing promise due to better understanding of genetics and the immune system.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

New treatments for severe alopecia areata show promise but lack standard approval.

The document concludes that various dermatological treatments and drugs can cause skin reactions and side effects.

Expand access to prevention and address barriers for sex workers in Kostanay.

Regulatory T cells adapt to different environments to control inflammation and support tissue repair.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

Mesenchymal stem cells improve skin appearance and structure in dermatology and aesthetic medicine.

IL-1 family cytokines are crucial for skin defense and healing, but their imbalance can cause skin diseases.

Nonantibiotic macrolides show promise for treating various inflammatory skin conditions.

Allergic rhinitis increases hair loss risk, but antihistamines can reduce it.

Alopecia Areata affects 2% globally, with treatments like essential oils, garlic, and JAK inhibitors showing promise, but more research is needed.

Th22 cells are essential for Tβ15-induced hair growth in mice.